Frontlight ResearchEarly access
Endometrial cancer trials in United States
199 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Where
- Boston, Chicago, Houston, La Jolla, Los Angeles, New York, Portland, Richmond, San Antonio, San Francisco
- Age
- 18 years to 130 years
- People
- 695 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05417594 · EU 2023-504984-17-00 - Phase 1/2Taking peoplePhase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Where
- Aurora, Boston, Columbus, Detroit, Duarte, Fairfax, Houston, Irvine, La Jolla, Louisville, Portland, Providence
- Age
- 18 years to 130 years
- People
- 622 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05797168 · EU 2022-502576-23-00 - Phase 1Taking peopleA Study of PHST001 in Advanced Solid Tumors
- Where
- Ann Arbor, Beverly Hills, Boston, Chicago, Denver, Durham, Fairfax, Fort Worth, Grand Rapids, Houston, Irving, Lake Success, Los Angeles, Nashville, New Haven, New York, Palo Alto, San Antonio
- Age
- 18 years and over
- People
- 426
- Run by
- Pheast Therapeutics
See details and how to joinNCT06840886 - Phase 1/2Taking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Austin, Bedford, Boston, Charleston, Cleveland, Dallas, Denver, Detroit, Durham, Fairfax, Houston, Irvine, La Jolla, Los Angeles, Madison, Miami, Nashville, Newark, New Haven, New York, Oklahoma City, Orlando, Philadelphia, Pittsburgh, Port Charlotte, Portland, San Antonio, Seattle, York
- Age
- 12 years and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - Early phase 1Taking peopleTirzepatide in Obesity-Driven Endometrial Cancer
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 20
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07065552 - Phase 1/2Taking people177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- Where
- Dothan, Grand Rapids, Houston, Omaha
- Age
- 18 years and over
- People
- 61
- Run by
- Radiopharm Theranostics, Ltd
See details and how to joinNCT07189871 - Phase 2Not yet taking people in United StatesSemaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 48
- Run by
- The Methodist Hospital Research Institute
See details and how to joinNCT07820358 - Phase 2Taking peopleThe Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 27
- Run by
- Mayo Clinic
See details and how to joinNCT07285044 - Phase 1Taking peopleA Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
- Where
- Fairfax, Maumee, Portland
- Age
- 18 years and over
- People
- 74
- Run by
- TwoStep Therapeutics, Inc.
See details and how to joinNCT07814248 - Phase 1/2Taking peopleStudy of AVZO-021 in Patients With Advanced Solid Tumors
- Where
- Cleveland, Dallas, Fairfax, Mineola, New Haven, New York, Oklahoma City, Philadelphia, Portland, Sarasota, Tampa
- Age
- 18 years and over
- People
- 430 worldwide
- Run by
- Avenzo Therapeutics, Inc.
See details and how to joinNCT05867251 - Phase 2Not yet taking people in United StatesTirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 40
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07078838 - Phase 1/2Taking peopleStudy of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- Where
- Birmingham, Boston, Buffalo, Columbus, Houston, Nashville, New York, Oklahoma City, Richmond, Rochester
- Age
- 18 years and over
- People
- 890 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT03564340 · EU 2024-510783-23-00 - No phaseTaking peopleDESTINY-PANTUMOUR04
- Where
- Birmingham, Boulder, Bullhead City, Canton, Casa Grande, Coral Springs, Dallas, Decatur, Durham, Farmington, Maumee, Nashville, Philadelphia, San Diego, St. Petersburg, Topeka, West Palm Beach, Wilson
- Age
- 18 years to 130 years
- People
- 100
- Run by
- AstraZeneca
See details and how to joinNCT07124000 - No phaseTaking peoplectDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 30
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07270666 - Phase 1/2Taking peopleA Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- Where
- Boston, Chicago, Columbus, Detroit, Duarte, Irvine, New York, Orange, Philadelphia, Seattle, Tampa
- Age
- 18 years and over
- People
- 612 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT04590326 · EU 2022-501904-83-00 - Phase 1Taking peopleA Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Where
- New Have, Santa Monica
- Age
- 18 years and over
- People
- 76 worldwide
- Run by
- Kivu Bioscience Inc.
See details and how to joinNCT07229313 - Phase 2Taking peoplePembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance
- Where
- Miami
- Age
- 18 years and over
- People
- 46
- Run by
- University of Miami
See details and how to joinNCT07594015 - Phase 2Taking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Albuquerque, Boston, Cincinnati, Columbus, Commack, East Brunswick, Grand Rapids, Houston, Kansas City, Los Angeles, Madison, Muncie, Nashville, Portland, San Diego, Santa Rosa
- Age
- 18 years to 130 years
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - Phase 1/2Taking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Aurora, Boston, Dallas, Detroit, Duarte, Fairfax, Grand Rapids, Houston, Indianapolis, Irving, Nashville, New York, Oklahoma City, Orange, Pittsburgh, Sacramento, San Antonio, Sarasota, Stanford, Tampa
- Age
- 18 years and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - Phase 1Taking peopleEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Where
- Aurora, Beverly Hills, Boston, Chicago, Duarte, Fairfax, Greenville, Houston, Iowa City, Louisville, Miami, Nashville, New Haven, New York, Orange, Orlando, Port Saint Lucie, Santa Monica, Seattle, Washington D.C.
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- SystImmune Inc.
See details and how to joinNCT05983432 - Phase 2Taking peopleA Study of Ivonescimab in People With Endometrial and Cervical Cancers
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 50
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06925724 - Phase 2Taking peoplePROton Therapy for Post Surgical Treatment of GYNecologic Cancer
- Where
- Lancaster, Philadelphia, Voorhees Township
- Age
- 18 years and over
- People
- 25
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT05758688 - No phaseTaking peopleEndometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women
- Where
- Houston
- Age
- 18 years and over
- People
- 45
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06409052 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Appleton, Aurora, Birmingham, Boston, Broomall, Chandler, Chapel Hill, Cincinnati, Cleveland, Dallas, East Brunswick, Edinburg, Forth Worth, Grand Rapids, Hollywood, Hot Springs, La Jolla, Lakeland, Lewiston, Myrtle Beach, New Orleans, Newport Beach, New York, Philadelphia, Redwood City, Rochester, Rock Hill, Sacramento, Salt Lake City, San Antonio, Shreveport, Toledo, York
- Age
- 18 years and over
- People
- 2,285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - Early phase 1Not yet taking people in United StatesTirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer
- Where
- Hershey
- Age
- 18 years and over
- People
- 15
- Run by
- Milton S. Hershey Medical Center
See details and how to joinNCT07812636